Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.
2.

Metabolism of LY654322, a growth hormone secretagogue, to an unusual diimidazopyridine metabolite.

Borel AG, Jones TM, Barbuch RJ, Jackson DA, Kulanthaivel P, Mattiuz E, Klimkowski VJ, Wheeler WJ, Rener GA.

Drug Metab Dispos. 2011 May;39(5):740-9. doi: 10.1124/dmd.110.037598. Epub 2011 Feb 23.

PMID:
21346003
3.

Selective reduction of N-oxides to amines: application to drug metabolism.

Kulanthaivel P, Barbuch RJ, Davidson RS, Yi P, Rener GA, Mattiuz EL, Hadden CE, Goodwin LA, Ehlhardt WJ.

Drug Metab Dispos. 2004 Sep;32(9):966-72.

PMID:
15319338
4.

Kinetics of association and dissociation of two enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(-) (CI 980), to tubulin.

Barbier P, Peyrot V, Dumortier C, D'Hoore A, Rener GA, Engelborghs Y.

Biochemistry. 1996 Feb 13;35(6):2008-15.

PMID:
8639685
6.

Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.

Pettit GR, Temple C Jr, Narayanan VL, Varma R, Simpson MJ, Boyd MR, Rener GA, Bansal N.

Anticancer Drug Des. 1995 Jun;10(4):299-309.

PMID:
7786396
7.

Phosphonate analogs of carbocyclic nucleotides.

Elliott RD, Rener GA, Riordan JM, Secrist JA 3rd, Bennett LL Jr, Parker WB, Montgomery JA.

J Med Chem. 1994 Mar 18;37(6):739-44.

PMID:
8145223
8.

Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.

de Ines C, Leynadier D, Barasoain I, Peyrot V, Garcia P, Briand C, Rener GA, Temple C Jr.

Cancer Res. 1994 Jan 1;54(1):75-84.

9.

Tubulin binding of two 1-deaza-7,8-dihydropteridines with different biological properties: enantiomers NSC 613862 (S)-(-) and NSC 613863 (R)-(+).

Leynadier D, Peyrot V, Sarrazin M, Briand C, Andreu JM, Rener GA, Temple C Jr.

Biochemistry. 1993 Oct 12;32(40):10675-82.

PMID:
8399213
11.

Antimitotic agents: structure-activity studies with some pyridine derivatives.

Temple C Jr, Rener GA, Waud WR, Noker PE.

J Med Chem. 1992 Oct 2;35(20):3686-90.

PMID:
1433180
13.

Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates.

Temple C Jr, Rener GA, Comber RN, Waud WR.

J Med Chem. 1991 Nov;34(11):3176-81.

PMID:
1956035
15.
16.
17.

Synthesis of potential anticancer agents: imidazo[4,5-c]pyridines and imidazo[4,5-b]pyridines.

Temple C Jr, Rose JD, Comber RN, Rener GA.

J Med Chem. 1987 Oct;30(10):1746-51.

PMID:
3656351

Supplemental Content

Loading ...
Support Center